Signal2026-06-26
ClinicalTrials.gov

[PHASE2] Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Part of

Emerging Cancer Biomarker Techniques

Open primary sourceSee the whole picture